-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PLgy8Hngn6Dp74Z5Nl1st9ELoKcFvLAvBiHZwtNuTY1H1TjTraVLMY42qudLM6n8 1oDeBHqDSNbw+Y0PljKT2A== 0001193125-09-258163.txt : 20091222 0001193125-09-258163.hdr.sgml : 20091222 20091222172317 ACCESSION NUMBER: 0001193125-09-258163 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091222 DATE AS OF CHANGE: 20091222 EFFECTIVENESS DATE: 20091222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MTS MEDICATION TECHNOLOGIES, INC /DE/ CENTRAL INDEX KEY: 0000823560 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT [3560] IRS NUMBER: 592740462 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-31578 FILM NUMBER: 091256111 BUSINESS ADDRESS: STREET 1: 2003 GANDY BOULEVARD NORTH CITY: ST. PETERSBURG STATE: FL ZIP: 33702 BUSINESS PHONE: 7275766311 MAIL ADDRESS: STREET 1: 2003 GANDY BOULEVARD NORTH CITY: ST. PETERSBURG STATE: FL ZIP: 33702 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL TECHNOLOGY SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 15-12B 1 d1512b.htm FORM 15 Form 15
OMB APPROVAL

OMB Number:

   3235-0167

Expires:

   November 30, 2010

Estimated average burden

hours per response

   1.50

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION

12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-31578

MTS Medication Technologies, Inc.

 

(Exact name of registrant as specified in its charter)

2003 Gandy Boulevard North, St. Petersburg, Florida 33702, (727) 576-6311

 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, Par Value $0.01

 

(Title of each class of securities covered by this Form)

None

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

 

Rule 12g-4(a)(1)

   ¨
 

Rule 12g-4(a)(2)

   ¨
 

Rule 12h-3(b)(1)(i)

   x
 

Rule 12h-3(b)(1)(ii)

   ¨
 

Rule 15d-6

   ¨

Approximate number of holders of record as of the certification or notice date: 1

Pursuant to the requirements of the Securities Exchange Act of 1934, MTS Medication Technologies, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:    December 22, 2009      By:   

/s/ Michael P. Conroy

         Michael P. Conroy
         Vice President and Chief Financial Officer

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----